The company is prioritizing its resources to drive the continued growth of the OptimalMTP procedure, offering minimally invasive plating of first MTP joint fusion.
The launch grows the navigation platform with an updated station and software, designed to deliver a faster, more intuitive user experience for surgical teams.
Peer-reviewed evidence supports a scientific foundation for NanoFuse as a synthetic biologic for bone regeneration, with implications for a potential role in spinal fusion.
The system is guided by Fixator Assisted Soft Tissue Repair, a framework that incorporates soft tissue protection, offloading, and support directly into the external fixation construct.